Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 1997

View Archived Issues

Japanese researchers focus on pyripyropenes

Prenyl-protein transferase inhibitors reported by Merck & Co.

Novel cephalosporins reported by Japanese investigators

Nippon Zoki claims aFGF fragments for CNS indications

New vitamin D derivatives from Duphar

Lilly claims IGF-1 superagonists

New AIDS vaccine candidates reported by Institut Pasteur

Fluoxetine plus dexfenfluramine effective in obese patients

Another new application for botulinum toxin reported in the literature

TxA2 antagonists modulate tumor sensitivity to platinum anticancer drugs

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Lipid effects of two gestodene/ethinylestradiol combinations compared

German investigators present potent dopamine D1 antagonist

Two FDA approvals for Taro

Watson/Royce merger approved

Watson's first NDA product approved

FDA advisory panel to discuss penile implant guidelines

Andrx freed to market Dilacor XR bioequivalent

bFGF enters clinical trials for PVD

Generic antidiabetic agent approved by FDA

New HRT patch approved for launch in U.S.

Yale receives grant from Vion

FDA clears Rogaine generic

Procrit cleared for new indication

Biofield seeks approval for new breast cancer diagnostic system

Cambridge NeuroScience/Gladstone Institute AD collaboration

Cephalon files first NDA submission

First NDA submission for NeoPharm seeks approval for two indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...